SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novelos Therapeutics, Inc. Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic